KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 132 filers reported holding KALA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,000 | – | 30,842 | +1056.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 2,667 | -87.9% | 0.00% | – |
| Q3 2021 | $119,000 | +2.6% | 22,002 | 0.0% | 0.00% | – |
| Q2 2021 | $116,000 | -26.6% | 22,002 | -6.2% | 0.00% | – |
| Q1 2021 | $158,000 | -48.2% | 23,450 | -48.0% | 0.00% | – |
| Q4 2020 | $305,000 | +70.4% | 45,072 | +163.2% | 0.00% | – |
| Q2 2020 | $179,000 | +105.7% | 17,123 | +71.8% | 0.00% | – |
| Q1 2020 | $87,000 | +38.1% | 9,966 | -41.8% | 0.00% | – |
| Q4 2019 | $63,000 | +28.6% | 17,116 | +32.0% | 0.00% | – |
| Q3 2019 | $49,000 | +512.5% | 12,969 | +899.2% | 0.00% | – |
| Q2 2019 | $8,000 | +166.7% | 1,298 | +70.1% | 0.00% | – |
| Q4 2018 | $3,000 | -85.7% | 763 | -65.7% | 0.00% | – |
| Q3 2018 | $21,000 | +2000.0% | 2,226 | +3035.2% | 0.00% | – |
| Q1 2018 | $1,000 | – | 71 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |